Compare DERM & TONX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | TONX |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.6M | 248.4M |
| IPO Year | 2021 | N/A |
| Metric | DERM | TONX |
|---|---|---|
| Price | $7.79 | $2.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | 192.8K | ★ 721.3K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 7.29 |
| Revenue | ★ $59,399,000.00 | $7,760,000.00 |
| Revenue This Year | $18.34 | $526.82 |
| Revenue Next Year | $54.69 | $45.45 |
| P/E Ratio | ★ N/A | $0.43 |
| Revenue Growth | 2.82 | ★ 3760.70 |
| 52 Week Low | $3.54 | $2.73 |
| 52 Week High | $9.40 | $29.77 |
| Indicator | DERM | TONX |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | N/A |
| Support Level | $7.52 | N/A |
| Resistance Level | $8.53 | N/A |
| Average True Range (ATR) | 0.42 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 40.48 | 0.00 |
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.